Cargando…
Placental alkaline phosphatase as a tumour marker in seminoma using the H17 E2 monoclonal antibody assay.
Serum samples from 62 patients with seminoma were assayed for placental alkaline phosphatase-like activity using the monoclonal antibody H17 E2, in order to evaluate its utility as a serum tumour marker. Fifteen of 16 patients (94%) with active seminoma had elevated serum PLAP levels. Sixteen of 46...
Autores principales: | Horwich, A., Tucker, D. F., Peckham, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977054/ https://www.ncbi.nlm.nih.gov/pubmed/3994907 |
Ejemplares similares
-
Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours.
por: Epenetos, A. A., et al.
Publicado: (1985) -
Serum marker potential of placental alkaline phosphatase-like activity in testicular germ cell tumours evaluated by H17E2 monoclonal antibody assay.
por: Tucker, D. F., et al.
Publicado: (1985) -
Tumour and cellular localization by use of monoclonal and polyclonal antibodies to placental alkaline phosphatase.
por: Jeppsson, A., et al.
Publicado: (1984) -
An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).
por: Munro, A. J., et al.
Publicado: (1991) -
An immunohistological study of testicular germ cell tumours using two different monoclonal antibodies against placental alkaline phosphatase.
por: Epenetos, A. A., et al.
Publicado: (1984)